PDSB

SEC source: 0001140361-26-007647 · form4.xml · derivative · entry 1

Shepard Kirk V. · CIK 0002009007 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2036-01-12

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-26-007645 · form4.xml · derivative · entry 1

Brown Spencer D. · CIK 0001930908 · Senior VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2036-01-12

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-26-007642 · form4.xml · derivative · entry 1

Iliev Ilian · CIK 0001808804 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,876

Underlying: Common Stock · 54,876 shares

Expires 2036-01-12

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-26-007641 · form4.xml · derivative · entry 1

Ali-Jackson Kamil · CIK 0001654337 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,876

Underlying: Common Stock · 54,876 shares

Expires 2036-01-12

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-26-007643 · form4.xml · derivative · entry 1

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,876

Underlying: Common Stock · 54,876 shares

Expires 2036-01-12

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-26-007649 · form4.xml · derivative · entry 1

BEDU-ADDO FRANK · CIK 0001770756 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 548,782

Underlying: Common Stock · 548,782 shares

Expires 2036-01-12

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-26-007648 · form4.xml · derivative · entry 1

CONN GREGORY · CIK 0001770008 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2036-01-12

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-26-007646 · form4.xml · derivative · entry 1

Boesgaard Lars · CIK 0001403893 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2036-01-12

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-26-007644 · form4.xml · derivative · entry 1

Toutain Stephan · CIK 0001681658 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2036-01-12

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 12, 2027, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-26-007640 · form4.xml · derivative · entry 1

BRAWLEY OTIS W · CIK 0001213029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,876

Underlying: Common Stock · 54,876 shares

Expires 2036-01-12

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-26-007639 · form4.xml · derivative · entry 1

Glover Stephen C. · CIK 0001304406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,876

Underlying: Common Stock · 54,876 shares

Expires 2036-01-12

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-25-027404 · form4.xml · derivative · entry 1

Shepard Kirk V. · CIK 0002009007 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-027403 · form4.xml · derivative · entry 2

Brown Spencer D. · CIK 0001930908 · Senior VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2035-06-12

F2 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-027405 · form4.xml · derivative · entry 2

BEDU-ADDO FRANK · CIK 0001770756 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2035-06-12

F2 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-027402 · form4.xml · derivative · entry 1

Boesgaard Lars · CIK 0001403893 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-027401 · form4.xml · derivative · entry 2

CONN GREGORY · CIK 0001770008 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2035-06-12

F2 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-027400 · form4.xml · derivative · entry 1

Toutain Stephan · CIK 0001681658 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2035-06-12

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on June 12, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-022226 · form4.xml · derivative · entry 1

Iliev Ilian · CIK 0001808804 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-25-022225 · form4.xml · derivative · entry 1

Ali-Jackson Kamil · CIK 0001654337 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-25-022224 · form4.xml · derivative · entry 1

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-25-022227 · form4.xml · derivative · entry 1

BRAWLEY OTIS W · CIK 0001213029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-25-022223 · form4.xml · derivative · entry 1

Glover Stephen C. · CIK 0001304406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,700

Underlying: Common Stock · 22,700 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-25-006784 · form4.xml · derivative · entry 2

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,060

Underlying: Common Stock · 15,060 shares

Expires 2030-02-28

F1 · price: The purchase price for the Common Warrant is included in the purchase price for the shares of Common Stock reflected in Table I above.

SEC source: 0001140361-25-006784 · form4.xml · nonDerivative · entry 1

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,213

SEC source: 0001140361-25-006783 · form4.xml · derivative · entry 2

Glover Stephen C. · CIK 0001304406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,061

Underlying: Common Stock · 15,061 shares

Expires 2030-02-28

F1 · price: The purchase price for the Common Warrant is included in the purchase price for the shares of Common Stock reflected in Table I above.

SEC source: 0001140361-25-006783 · form4.xml · nonDerivative · entry 1

Glover Stephen C. · CIK 0001304406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,851

SEC source: 0001140361-24-031291 · form4.xml · derivative · entry 1

Iliev Ilian · CIK 0001808804 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-24-031289 · form4.xml · derivative · entry 1

Ali-Jackson Kamil · CIK 0001654337 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-24-031294 · form4.xml · derivative · entry 1

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-24-031293 · form4.xml · derivative · entry 1

Glover Stephen C. · CIK 0001304406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-24-031292 · form4.xml · derivative · entry 1

SYKES RICHARD · CIK 0001372810 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-24-031290 · form4.xml · derivative · entry 1

BRAWLEY OTIS W · CIK 0001213029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2034-06-24

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-24-024002 · form4.xml · derivative · entry 1

Toutain Stephan · CIK 0001681658 · Chief Operations Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-05-01

F1 · derivative.exercise_date: The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on May 1, 2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-027403 · form4.xml · derivative · entry 1

Brown Spencer D. · CIK 0001930908 · Senior VP, General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,000

Underlying: Common Stock · 56,000 shares

Expires 2034-02-28

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on February 28,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-027405 · form4.xml · derivative · entry 1

BEDU-ADDO FRANK · CIK 0001770756 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2034-02-28

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on February 28,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-25-027401 · form4.xml · derivative · entry 1

CONN GREGORY · CIK 0001770008 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,648

Underlying: Common Stock · 46,648 shares

Expires 2034-02-28

F1 · derivative.exercise_date: The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on February 28, 2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-24-003434 · form4.xml · derivative · entry 1

Shepard Kirk V. · CIK 0002009007 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2034-01-22

F1 · derivative.exercise_date: The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 22,2025, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-23-056240 · form4.xml · derivative · entry 1

Boesgaard Lars · CIK 0001403893 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-12-04

F1 · derivative.exercise_date: The option was granted by the Issuer as an inducement material to the Reporting Person entering into employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4) and the Issuer's 2019 Inducement Plan, as amended. The option will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on December 4, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.

SEC source: 0001140361-23-034829 · form4.xml · derivative · entry 1

Iliev Ilian · CIK 0001808804 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2033-07-14

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-23-034836 · form4.xml · derivative · entry 1

Ali-Jackson Kamil · CIK 0001654337 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2033-07-14

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-23-034839 · form4.xml · derivative · entry 1

Freitag Gregory Gene · CIK 0001492710 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2033-07-14

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-23-034838 · form4.xml · derivative · entry 1

BRAWLEY OTIS W · CIK 0001213029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2033-07-14

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-23-034832 · form4.xml · derivative · entry 1

SYKES RICHARD · CIK 0001372810 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2033-07-14

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-23-034831 · form4.xml · derivative · entry 1

Glover Stephen C. · CIK 0001304406 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2033-07-14

F1 · derivative.exercise_date: The Stock Option will vest in full and become fully exercisable on the first anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer as a director through such date.

SEC source: 0001140361-23-000827 · form4.xml · derivative · entry 1

Brown Spencer D. · CIK 0001930908 · Senior VP, General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,400

Underlying: Common Stock · 20,400 shares

Expires 2033-01-05

F1 · derivative.exercise_date: This option, representing a right to purchase a total of 20,400 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027.

SEC source: 0001140361-23-000825 · form4.xml · derivative · entry 1

CONN GREGORY · CIK 0001770008 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,200

Underlying: Common Stock · 137,200 shares

Expires 2033-01-05

F1 · derivative.exercise_date: This option, representing a right to purchase a total of 137,200 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027.

SEC source: 0001140361-23-000826 · form4.xml · derivative · entry 1

HILL MATTHEW C · CIK 0001278675 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,200

Underlying: Common Stock · 161,200 shares

Expires 2033-01-05

F1 · derivative.exercise_date: This option, representing a right to purchase a total of 161,200 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027.

SEC source: 0001140361-23-000824 · form4.xml · derivative · entry 1

BEDU-ADDO FRANK · CIK 0001770756 · Director · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 385,300

Underlying: Common Stock · 385,300 shares

Expires 2033-01-05

F1 · derivative.exercise_date: This option, representing a right to purchase a total of 385,300 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027.

SEC source: 0001140361-23-000823 · form4.xml · derivative · entry 1

WOOD LAUREN · CIK 0001769757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,800

Underlying: Common Stock · 110,800 shares

Expires 2033-01-05

F1 · derivative.exercise_date: This option, representing a right to purchase a total of 110,800 shares of Common Stock, will become exercisable on January 5, 2024, with 25% vesting on that date and the remaining 75% vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 5, 2027.

SEC source: 0001140361-22-044259 · form4.xml · derivative · entry 3

BEDU-ADDO FRANK · CIK 0001770756 · Director · President/CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 219,535 shares

Expires 2022-12-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This stock option was fully vested in accordance with its terms.